Brand, payer marketing, market access, and managed markets teams: Are you prepared for a call from the boardroom to review your brand’s value proposition and forecast in a world without rebates?
As you know, to address rising drug costs, the …
It’s not often that we hear pharma clients communicate high satisfaction with their KAM approach and sales performance, and that’s to be understood. For many reasons, it’s a tough undertaking. Multiproduct clinical knowledge, new selling skills, complex market knowledge, inadequate …
If you are on the brand, market access, or managed markets team at your pharmaceutical company, likely you are already well aware of the recent proposal by the Department of Health and Human Services (HHS) to remove safe harbor protections …
The number of pharmaceutical sales representatives has declined nationwide from about 120,000 to around 70,000. Meanwhile, provider expectations of our sales teams have risen.
More than 115 people in the United States die every day from opioid overdose.1Since the 1990s, the use of opioids to treat moderate to severe pain has increased dramatically. The current federal administration has declared it an epidemic. …